Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Clinical Pharmacology and Therapeutics|December 15, 2015
Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemiaC D Drenberg, S W Paugh, S B Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemiaC H Pui, J E Rubnitz, M L Hancock, et al.
Clinical Pharmacology and Therapeutics|August 9, 2012
Concordance of DMET plus genotyping results with those of orthogonal genotyping methodsC A Fernandez, C Smith, W Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxinB Waurzyniak, E A Schneider, N Tumer, et al.
Leukemia|March 14, 2009
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1S Jeha, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Late effects of treatment in survivors of childhood acute myeloid leukemiaW Leung, M M Hudson, D K Strickland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significanceJ E Rubnitz, J R Downing, C H Pui, et al.
Clinical Pharmacology and Therapeutics|June 18, 2016
Comparison of genome sequencing and clinical genotyping for pharmacogenesW Yang, G Wu, U Broeckel, et al.
Pageof 28